Nuvectis Pharma, Inc. (NVCT)
NASDAQ: NVCT · Real-Time Price · USD
8.26
+0.03 (0.36%)
At close: Mar 23, 2026, 4:00 PM EDT
8.26
0.00 (0.00%)
After-hours: Mar 23, 2026, 4:52 PM EDT
Nuvectis Pharma Market Cap
Nuvectis Pharma has a market cap or net worth of $218.82 million as of March 23, 2026. Its market cap has increased by 52.11% in one year.
Market Cap
218.82M
Enterprise Value
187.19M
1-Year Change
52.11%
Ranking
Category
Stock Price
$8.26
Market Cap Chart
Since the IPO on February 4, 2022, Nuvectis Pharma's market cap has increased from $58.01M to $218.82M, an increase of 277.24%. That is a compound annual growth rate of 37.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 218.03M | 12.74% |
| Dec 31, 2025 | 193.39M | 85.02% |
| Dec 31, 2024 | 104.53M | -27.67% |
| Dec 29, 2023 | 144.50M | 31.58% |
| Dec 30, 2022 | 109.82M | 89.32% |
| Feb 4, 2022 | 58.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cybin | 231.17M |
| Voyager Therapeutics | 229.16M |
| Editas Medicine | 229.02M |
| Coherus Oncology | 227.83M |
| Alector | 226.24M |
| Eledon Pharmaceuticals | 218.45M |
| MediWound | 217.68M |
| Keros Therapeutics | 216.10M |